Nuwellis, Inc. (NUWE)
0.7878
+0.01
(+0.88%)
USD |
NASDAQ |
Sep 08, 16:00
0.8099
+0.02
(+2.81%)
Pre-Market: 09:15
Nuwellis Enterprise Value : -3.259M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | -3.259M |
| September 04, 2026 | -3.263M |
| September 03, 2026 | -3.290M |
| September 02, 2026 | -3.287M |
| September 01, 2026 | -3.277M |
| August 31, 2026 | -3.257M |
| August 28, 2026 | -3.201M |
| August 27, 2026 | -3.144M |
| August 26, 2026 | -3.132M |
| August 25, 2026 | -3.161M |
| August 24, 2026 | -3.109M |
| August 21, 2026 | -3.046M |
| August 20, 2026 | -3.069M |
| August 19, 2026 | -3.040M |
| August 18, 2026 | -3.028M |
| August 17, 2026 | -2.988M |
| August 14, 2026 | -2.959M |
| August 13, 2026 | -2.965M |
| August 12, 2026 | -2.902M |
| August 11, 2026 | -2.862M |
| August 10, 2026 | -2.896M |
| August 07, 2026 | -2.856M |
| August 06, 2026 | -2.776M |
| August 05, 2026 | -2.730M |
| August 04, 2026 | -2.632M |
| Date | Value |
|---|---|
| August 03, 2026 | -2.787M |
| July 31, 2026 | -2.712M |
| July 30, 2026 | -1.156M |
| July 29, 2026 | -2.626M |
| July 28, 2026 | -2.603M |
| July 27, 2026 | -2.569M |
| July 24, 2026 | -2.534M |
| July 23, 2026 | -2.448M |
| July 22, 2026 | -2.075M |
| July 21, 2026 | -2.075M |
| July 20, 2026 | -1.988M |
| July 17, 2026 | -2.075M |
| July 16, 2026 | -2.023M |
| July 15, 2026 | -1.920M |
| July 14, 2026 | -1.862M |
| July 13, 2026 | -2.103M |
| July 10, 2026 | -1.966M |
| July 09, 2026 | -2.057M |
| July 08, 2026 | -2.063M |
| July 07, 2026 | -1.902M |
| July 06, 2026 | -1.822M |
| July 02, 2026 | -1.902M |
| July 01, 2026 | -1.908M |
| June 30, 2026 | -1.960M |
| June 29, 2026 | -1.570M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| GlucoTrack, Inc. | 2.058M |
| Abbott Laboratories | 210.25B |
| AngioDynamics, Inc. | 591.77M |
| Alphatec Holdings, Inc. | 1.912B |
| AtriCure, Inc. | 2.639B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.828M |
| Revenue (Quarterly) | 1.969M |
| Total Expenses (Quarterly) | 6.797M |
| EPS Diluted (Quarterly) | -26.63 |
| Gross Profit Margin (Quarterly) | 76.08% |
| Profit Margin (Quarterly) | -245.2% |
| Earnings Yield | -17.27K% |
| Normalized Earnings Yield | -31287.95 |